Skip to main content

Table 1 Demographic, blood chemistry and sleep apnea measures for patients and controls participating in the experiments

From: Bax/Mcl-1 balance affects neutrophil survival in intermittent hypoxia and obstructive sleep apnea: effects of p38MAPK and ERK1/2 signaling

No Age BMI AHI % TO Sat <90% TG (mg/dL) Cholest. (mg/dL) HDL (mg/dL) LDL (mg/dL) Glucose (mg/dL)
1 OSA 62 25.2 22 17.3 203.9 183 26.8 115.6 87.2
2 OSA 64 27.4 19 2.2 50.5 215 81 124.3 88.3
3 OSA 48 34.2 33 6.8 79.9 154 60.4 77.5 95.9
4 OSA# 74 35.9 61 50.2 116.7 118 46.3 48.4 71.3
5 OSA*# 42 27.1 15 21.5 80.6 188 35.7 136.2 102.3
6 OSA 33 37.6 65 45.1 217.2 145 28.8 72.8 105.9
7 OSA 37 24.7 35 1.9 82.7 161 48.3 96 91.8
Mean 51.4 30.2 35.7 20.7 118.8 166 46.8 95.8 91.8
SD 15.4 5.5 20.0 19.9 65.7 32.0 19.2 31.5 11.4
1 Cont. 57 23.4 9 0 123.7 193 51.5 116.6 87.1
2 Cont. 38 25.3 9 0 94.2 185 59 107.2 90.7
3 Cont. 57 25.9 6 0 295.0 227 28.3 140.1 89.2
Mean 50.7 24.9 8 0 171.0 201.7 46.3 121.3 89
SD 11 1.3 1.7   108.4 22.3 16 16.9 1.8
Mean 32.9 25.6 2.1 0 107.9 164.2 39.5 103.1 86.54.4
SD 9.6 2.9 1.8   60 16.6 7.4 18.1
  1. BMI – body mass index, Kg/m2; AHI – apnea hypopnea index; %TO2<90% - Percent time asleep with arterial oxygen saturation below 90%; TG - Triglycerides; Cholest.- Cholesterol; * - current smoker; # - irregular low-dose acetyl salicylic acid usage (micropirin-75); Individual data for obstructive sleep apnea (OSA) patients and 3 control subjects (cont.) which underwent full-night polysomnography (Technion Sleep Medicine Center, Haifa). Blood samples were withdrawn under fasting after polysomnography. † Mean ± SD of control subjects in which disordered breathing during sleep was ruled out by a validated home monitored device.